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Abstract: Dengue viruses (DENV) are by far the most important arboviral pathogens in 
the tropics around the world, putting at risk of infection nearly a third of the global human 
population. DENV are members of the genus Flavivirus in the Family Flaviviridae and 
comprise four antigenically distinct serotypes (DENV-1-4). Although they share almost 
identical epidemiological features, they are genetically distinct. Phylogenetic analyses have 
revealed valuable insights into the origins, epidemiology and the forces that shape DENV 
evolution in nature. In this review, we examine the current status of DENV evolution, 
including but not limited to rates of evolution, selection pressures, population sizes and 
evolutionary  constraints,  and  we  discuss  how  these  factors  influence  transmission, 
pathogenesis and emergence. 
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1. Introduction  
Dengue viruses (DENV) are arthropod-borne viruses (arboviruses) in the genus Flavivirus (family 
Flaviviridae)  with  positive  polarity,  single-stranded  RNA.  They  utilize  Aedes  (Stegomyia)  spp., 
primarily Ae. aegypti and Ae. albopictus, as vectors for domestic and peridomestic transmission, and 
arboreal Aedes mosquitoes as vectors for enzootic transmission (Figure 1). All DENV group into four 
genetically related but antigenically distinct serotypes (DENV-1,  -2, -3  and -4) within the dengue 
(DEN) antigenic complex [1]. They are extremely restricted in their natural vertebrate host range, 
which  includes  only  primates  [2,3],  although  some  reports  suggest  for  a  putative,  unconfirmed, 
extended  vertebrate  host  range  [4–6].  After  World  War  II  there  was  an  explosive  increase  in  the 
geographic  distribution  of  all  four  DENV  serotypes  fueled  by  uncontrolled  urbanization,  rapid 
population movement facilitated by jet travel, inadequate water, sewer and waste management, as well 
as unsustainable vector control programs [7]. At present, all four DENV serotypes can be found in 
nearly  all  urban  and  peri-urban  environments  throughout  the  tropics  and  subtropics  where  Aedes 
(Stegomyia) aegypti aegypti and Ae. (Stegomyia) albopictus are present. Thus the global distribution 
of these two major vectors puts nearly a third of the global human population at risk of infection [8]. 
Currently DEN has become endemic in more than 100 countries and the disease is spreading to new 
areas where outbreaks take place in immunologically naïve populations [9,10]. 
Figure 1. The Transmission Cycles of Dengue Virus (DENV). The transmission cycles of 
DENV, depicting the sylvatic origins and the ‘zone of emergence’ where sylvatic cycles 
contact  human  populations  in  rural  areas  in  West  Africa  and  Southeast  Asia.  Image 
courtesy of Shannan Rossi, Department of Pathology, UTMB.  
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By current estimates, the impact of DENV infections on human health is enormous; DENV are 
responsible for ca. 100 million infections per year presenting in a spectrum of clinical manifestations. 
While the great majority of infections are accompanied by little no or subclinical signs and symptoms, 
symptomatic  infections  commonly  manifest  as  a  self-limited  flu-like  disease  [dengue  fever  (DF)] 
characterized by a sudden onset of fever, arthralgia, myalgia, retro-orbital headaches, maculopapular 
rash, and leucopenia. Approximately 1–2% of human infections present clinically as the most severe 
form of the disease [dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS)], characterized by 
vascular leakage and/or hemorrhage, leading to ca. 500,000 annual hospitalizations with a case fatality 
rate  of  about  5%  [11].  Although  severe  DEN  disease  is  historically  associated  with  pediatric 
populations  in  hyperendemic  regions  (areas  in  which  circulation  of  all  4  DENV  serotypes  takes  
place) [12–14], recent trends from Southeast Asia and Latin America suggest that adults may also be at 
risk [15–23]. Risk factors for the development of severe DEN disease include prior infection with a 
heterotypic  serotype  [24–26],  the  strain  of  the  infecting  virus  [27–29],  age  and  gender  [30,31], 
nutritional status [32,33] and the genetic background of the patient [34–36]. Because of underreporting 
of disease and under-utilization of health services especially in resource-poor countries, the true health 
and economic burden due to DENV infections is difficult to estimate [37]. Nonetheless, it is estimated 
that in the endemic areas of Asia and the Americas, the burden of DEN is in the range 150–1,300 
disability adjusted life years (DALY) per million, depending on the spatiotemporal attributes of the 
epidemics [8,38–42] (reviewed in [43]), and the costs associated with a DENV infection significantly 
exceed the average monthly income of the patient [38,42,44–52].  
In this review, we examine the current status of DENV evolution, including but not limited to rates 
of evolution, selection pressures, population sizes and evolutionary constraints, and discuss how these 
factors influence transmission, pathogenesis and emergence. 
2. History, Origin and Emergence of DENV 
DENV undoubtedly have a long history of infecting humans. The earliest known references date 
back to the Chin, Tang and Northern Sung Dynasties [Common Era (CE) 265–420, 610 and 992 AD 
respectively]  describing  a  disease  referred  to  as  ‘water  poison,’  clearly  for  its  association  with 
water-associated insects [7,53]. Since Ae. aegypti aegypti, the primary vector of DENV transmission 
has been introduced in Asia through the sailing ship trade a few hundred years ago, the likely vector of 
transmission at that time would have been Ae. albopictus. The next available reports first appeared in 
the  17th  Century  and  for  the  next  two  centuries  describe  a  disease  with  widespread  geographic 
distribution fueled by the sailing ship and slave trade, which reached pandemic proportions by the  
late 18th Century [54–57] (reviewed in [7,58]). Although the clinical manifestations are consistent 
with a DEN-like disease, including fever, rash, arthralgia, myalgia and hemorrhagic manifestations, it 
is possible that the described illness was due to other aetiologic agents [for example chikungunya virus 
(CHIKV)] that produce illness often indistinguishable from DEN [54,59,60].  
Many  aspects  of  the  origin  and  evolution  of  DENV  remain  unclear  to  this  day.  It  has  been 
hypothesized  that  the  human  DENV  that  circulate  widely  today  in  urban  and  peri-urban  centers 
throughout the tropics and neotropics evolved from sylvatic progenitors [7,61]. Phylogenetic analyses 
of available DENV gene sequences have shed some light on DENV evolutionary history [58,62–70] Viruses 2011, 3                         
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(Figures 2–5). These analyses indicate that all current distinct DENV serotypes evolved independently 
and repeatedly in a series of divergence events that occurred after the establishment of large enough 
urban populations to support the human transmission cycle [63,64,67,71,72]. This emergence process 
was  facilitated  through  vector  switching,  from  arboreal  Aedes  mosquitoes  to  peridomestic 
(Ae. albopictus) and domestic (Ae. aegypti aegypti) mosquitoes and switching of reservoir hosts from 
non-human primates to humans (Figure 1). Furthermore, the emergence of the extant, distinct human 
DENV strains from the sylvatic transmission cycle was most likely facilitated by the allopatric and 
perhaps ecological partitioning of ancestral sylvatic DENV strains in different species of non-human 
primate populations. The onset of transoceanic exploration in the 15th Century and the subsequent 
establishment of trading routes and waves of human immigration provided the means for the dispersal 
of the four DENV sylvatic serotypes and the elimination of their allopatric distributions. By then the 
four serotypes had diverged antigenically to support the limited heterotypic cross-protection against 
challenge  exhibited  by  current  strains  of  DENV  [73,74].  This  reality  evidently  released  the  four 
serotypes  from  direct  competition  for  susceptible  hosts,  thus  allowing  for  their  sympatry  due  to 
incomplete cross-protection, which presumably  reduce  competition for a common host population. 
Therefore,  the  currently  observed  coexistence  of  multiple  serotypes  with  their  extensive  genetic 
diversity may have been and may still be selected by immune enhancement (enhancement of virus 
replication  following  heterologous  infection).  In  such  settings,  each  virus  gains  replication  and 
transmission efficiency in the human and/or non-human primate host due to limited cross-reactive 
immunity from previous, heterologous DENV infections [75–78] (SEE ‘Cross-Immunity as a Driving 
Force for DENV Evolution’ AND ‘Antibody-Dependent Enhancement (ADE) and Its Effect on DENV 
Evolution’ sections below). Indeed, several lines of evidence support the role of immune enhancement 
as a factor in the observed oscillations of DEN incidence [79,80]. Selection for higher virus replication 
facilitated by immune enhancement also may influence higher transmissibility by the mosquito vector. 
Since  Ae.  aegypti  aegypti  is  only  moderately  susceptible  to  DENV  infection,  selection  of  strains 
of higher  fitness  and  thus  higher  viremia  in  the  vertebrate  host  may  have  enhanced  its  capacity 
to spread these  in  new  territories  and  displace  endemic  strains  of  lower  fitness  and  pathogenic 
potential [77,81–83]. Thus, even if a vector is highly susceptible and the infection threshold is well 
below the typical viremia peak titer, higher viremia is usually accompanied by longer viremia such that 
the amount of time an individual is infectious for a vector is extended. 
The geographic origin of DENV has been subject to speculation and debate for decades. Based on 
the available data it is impossible to conclusively identify Asia versus Africa as the origin of DENV. 
Some have proposed the ultimate origins of DENV in Africa, based on the circulation there of several 
closely related mosquito-borne flaviviruses [84] and/or the African origin the principal DENV vector, 
Ae. aegypti aegypti [85]. The argument for the African origin of DENV parallels that of yellow fever 
virus  (YFV),  which  is  also  vectored  in  its  human  cycle  by  the  same  mosquito  species,  and  was 
introduced  into  the  Americas  during  the  slave  trade  ca.  300–400  years  ago,  where  it  established 
sylvatic cycles that persist today [86] and which repeatedly seeded spillover epidemics into the human 
transmission cycle [87,88]. Gordon Smith suggested the African origin of DENV based on the African 
origin of Ae. aegypti aegypti which was supported by the following lines of evidence: (i) abundance in 
Africa of the closely related Aedes (Stegomyia) spp.; (ii) the absence of related Aedes (Stegomyia) spp. 
in the Americas, and (iii) the Africa-only existence of sylvatic, ancestral Ae. aegypti formosus [89,90]. Viruses 2011, 3                         
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However, as discussed below (see ‘Transmission Cycles’ section) sylvatic DENV circulating in Africa 
do  not  utilize  Ae.  aegypti  formosus  as  a  vector,  and  recent  evidence  indicates  this  subspecies  is 
refractory to DENV infection [91–93]. Wang et al. [63] proposed an ‘out of Asia’ origin of DENV, 
based  on  the  following  ecologic  and  phylogenetic  evidence.  First,  all  4  sylvatic  DENV  serotypes 
circulate in Southeast Asia [although there is only serologic evidence of sylvatic DENV-3 circulation 
and  the  phylogeny  of  sylvatic  DENV-1  is  uncertain  (see  Sections  4.1  and  4.3)]  [2,58,63,69,94], 
whereas  only  sylvatic  DENV-2  transmission  has  been  documented  in  Africa  [95–97].  Second, 
extensive phylogenetic analyses demonstrate the deep phylogenetic positions of the Asian sylvatic 
strains [58,63,65,70,94,98]. Lastly, Ae. albopictus, a peridomestic mosquito of Asian origin but only a 
secondary vector for human DENV transmission [99], has been shown in experimental studies to be 
more susceptible to DENV virus infection than Ae. aegypti aegypti [100]. Furthermore, early serologic 
studies  (neutralizing  antibodies)  in  Southeast  Asia  in  human  populations  inhabiting  a  variety  of 
ecologic habitats devoid of Ae. aegypti aegypti [85] suggest that Ae. albopictus was the original vector 
for human DENV and that the virus exploited the anthropophagic nature and the extended geographic 
distribution of the domestic Ae. aegypti aegypti to facilitate the sustained, yet explosive, transmission 
among  humans  [7,101–103].  Regardless  of  the  arguments  presented  above,  it  is  clear  that  a  full 
understanding of the origins and evolutionary history of DENV will require a far larger sample of 
sylvatic viruses than is currently available. Furthermore, our understanding of DENV origins may be 
enhanced by extensive metagenomic surveys of flavivirus diversity, since we have undoubtedly only 
sampled a small fraction of the total diversity of flaviviruses [68–70,84,94,104]. 
3. Transmission Cycles 
The  four  DENV  serotypes  are  maintained  in  two  distinct  transmission  cycles:  (a)  sylvatic  and 
(b) human (Figure 1).  
The sylvatic cycle is ecologically and evolutionarily distinct from the human transmission cycle. It 
takes place in the sylvan environments of Southeast Asia and West Africa in well-documented foci in 
peninsular Malaysia [2] and eastern Senegal [95,105], respectively. Recent phylogenetic analyses have 
extended the spatiotemporal range in which sylvatic DENV are known to circulate in West Africa [97]. 
In  this  cycle,  transmission  is  mediated  by  arboreal  canopy-dwelling  Aedes  spp.  and  non-human 
primates  appear  to  be  the  only  amplification  and  reservoir  hosts.  In  Africa,  the  principal  vectors 
include  Ae.  (Stegomyia)  luteocephalus,  Ae.  (Diceromyia)  furcifer,  and  Ae.  (Diceromyia)  taylori 
(Figure 1) [95,96,105–107]. Although Ae. furcifer are primarily canopy-dwelling enzootic mosquitoes, 
they  are  known  to  descend  to  ground  level  to  feed  on  humans  [105].  Surprisingly,  the  arboreal, 
ancestral  form,  Ae.  aegypti  formosus,  of  the  major  domestic  vector  for  DENV  transmission  (see 
below), is refractory to sylvatic DENV infection [91,92,105]. The primate reservoir hosts in Africa 
include the Patas monkey (Erythrocebus patas), African green monkey (Chlorocebus sabaeus), Guinea 
baboon (Papio papio) [3,108] and possibly related species such as Papio anubis, Papio ursinus and 
Papio cynocephalus [94]. In Asia, the principle vectors include the primatophilic canopy-dwelling 
mosquitoes  of  the  Ae.  (Finlaya)  niveus  s.l.  complex,  a  group  that  includes  Ae.  pseudoniveus, 
Ae. subniveus, Ae. vanus, Ae. albolateralis, Ae. niveoides and Ae. novoniveus [2]. These species are 
also known to descend to the ground to feed on humans. The Asian primate reservoir hosts include, Viruses 2011, 3                         
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cynomolgus monkeys (Macaca fascicularis), Southern pig-tailed macaques (Macaca nemestrina) and 
silvered leaf monkeys (Presbytis cristata) and possibly green-mitered leaf monkeys (Presbytis melaphos) 
[2,109] (Figure 1). Although only two documented foci of sylvatic DENV transmission have been 
recognized, if one considers the extent of the geographic range of either vectors and primate reservoir 
hosts, it is probable that sylvatic DENV transmission occurs, yet undiscovered, in other locations of 
tropical Africa and Asia [94,110].  
To date there is no concrete evidence to document the existence of sylvatic DENV transmission 
cycle  in  the  Americas.  Although  several  species  of  New  World  non-human  primates,  including 
Cebus capucinus,  Ateles  geoffroyi,  Ateles  fusciceps,  Alouatta  palliata,  Marikina  geoffroyi,  Saimiri 
orstedii and Aotus trivirgatus, are susceptible to DENV infection [111], serological surveys (plaque 
neutralization) of non-human primates in Panama revealed no evidence of enzootic circulation [112]. 
However, seroconversions among indigenous Ayoreo Indians living in an isolated forested region of 
Bolivia, where Ae. aegypti aegypti are not present, suggests that sylvatic DENV transmission may 
occur in that region [113]. Recently, reported isolations of all four DENV serotypes in several forest 
mammals  including  bats,  rodents  and  marsupials  probably  represent  spillbacks  from  the  human 
transmission cycle [4,5]. 
The  opportunistic  feeding  behavior  of  the  arboreal  mosquito  vectors  described  above  could 
facilitate transfer of sylvatic DENV from the forest to peridomestic environments (Figure 1). Indeed, 
in rural areas of Africa and Asia where enzootic vector(s) often reach high densities, DENV is known 
to  transfer  between  non-human  primates  and  humans.  The  moist  savannahs  surrounding  sylvan 
environments in rural areas of Africa and Asia are defined as the ‘zone of emergence’ [114] (Figure 1). 
In Asia, the studies of Rudnick demonstrated that zoonotic Ae. niveus vectors descend to the ground to 
feed on humans, where Ae. albopictus are also abundant, thus allowing the transfer of virus into human 
habitats [115]. This scenario parallels what has been observed in rural areas adjacent to forests in 
West Africa, where Ae.  furcifer is probably the principal bridge vector  between forest and human 
habitats [105].  
Currently,  almost  all  human  infections  are  due  to  DENV  strains  that  circulate  exclusively  in 
domestic  and  peridomestic  environments  throughout  the  tropics,  where  humans  serve  as  the  sole 
amplification  and  reservoir  hosts.  In  this  human  cycle,  Ae.  aegypti  aegypti  mosquitoes  transmit 
DENV [116],  while  other  Aedes  spp.  (for  example,  Ae.  albopictus,  Ae.  polynesiensis)  serve  as 
secondary  vectors  [7,99,117,118]  (Figure  1).  As  described  above  (see  Section  4),  although 
Ae. albopictus may have been the original vector for human transmission, DENV have fully exploited 
the highly anthropophilic Ae. aegypti aegypti for sustained human transmission. This vector of African 
origin [119,120] (its ancestral form Ae. aegypti formosus utilizes treeholes as larval habitats), exploited 
the sailing ship trade routes of the 1700s, as well as water storage practices, to infest the tropics almost 
worldwide [101,121] and in Asia to displace in some locations the native vector [100], Ae. albopictus. 
Furthermore, its domesticated nature, which includes oviposition in artificial water containers leading 
to large numbers of adult mosquitoes in close proximity to humans, as well as its diurnal feeding 
pattern and endophilic behavior, permitted it to surpass in epidemiological importance all other Aedes 
spp. Other behaviors of Ae. aegypti aegypti that increase its vectorial capacity include its feeble and 
nervous nature, where feeding interruption at the slightest of movement leads to subsequent return to 
the same or different host, and its preference for blood over plant nectars for energetic needs. These Viruses 2011, 3                         
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behaviors increase the potential for this species to transmit a pathogen to several hosts within a very 
short time [122–124], overcoming the limitation of low oral susceptibility to DENV infection [125] 
and  thus  selecting  for  DENV  with  higher  fitness  (viremia)  and  associated  pathogenic  potential 
[27,126].  
Transovarial transmission (TOT) has also been suggested as a mechanism of DENV maintenance in 
both transmission cycles (Figure 1), especially during protracted dry seasons or interepidemic periods. 
The involvement of TOT in DENV maintenance was demonstrated in nature with the isolation of 
presumably sylvatic DENV-2 from a pool of Ae. taylori in 1980 in Côte d’Ivoire [96], and a year later 
in Senegal from a pool of Ae. furcifer mosquitoes [3]. DENV TOT has also been demonstrated in 
Ae. aegypti aegypti collected from diverse geographic locations and developmental stages [127–136], 
as  well  as  Ae.  albopictus  [100,137–139],  Ae.  mediovittatus  [140],  and  several  members  of  the 
Ae. (Stegomyia) scutellaris group, in which they play an important role in DENV transmission in the 
Indonesian archipelago and Western Pacific islands (Polynesia) [141]. 
4. Phylogeny as a Tool to Understand DENV Epidemiology and Evolution 
The  rapid  hyperendemicity  of  the  4  DENV  serotypes  in  the  aftermath  of  World  War  II  was 
characterized by rapid radiation [68], consistent with a pattern of intense diversification (‘boom and 
bust’ period) followed by lineage extinction (‘pruning’ period) and clade replacement [72,142–144] 
(see Section 6 below). This rapid expansion of diversity coincided with explosive human population 
growth, uncontrolled urbanization, and massive human movement. While early genetic comparisons 
relied on RNA fingerprinting [145–147] to group DENV strains into topotypes (strains sharing similar 
spatial distribution), direct viral RNA sequencing allowed for greater efficiency as well as precise 
characterization of DENV strains. This leap in technology allowed Rico-Hesse to delineate the precise 
evolutionary relationships of DENV-1 and -2 by introducing the term ‘genotype’ [62], defined as the 
clustering of DENV viruses with nucleotide sequence divergence not greater than 6% within a given 
genome region. As technology advanced, automated sequencing allowed for the utilization of complete 
genes  or  genomes  in  obtaining  more  robust  and  precise  phylogenies,  often  identifying  additional 
topotypes. Recently a concerted sequencing effort led by The Broad Institute in collaboration with a 
number of international research centers resulted in an exponential increase the deposition of complete 
genomic sequences into public databases. Although the availability of complete genomic sequences as 
well as advanced software tools provide a unique window into understanding how intrinsic factors 
such as selection pressures, evolutionary rates and population dynamics influence DENV evolution, 
they often exclude a wealth of previously acquired partial genomic sequences. In this review we will 
attempt to bridge this reality by constructing a phylogenetic history of all available E gene sequences 
for each of the four dengue serotypes. 
4.1. DENV-1 
Previous studies based on partial [62,148,149], complete E gene [98,142,144,150–155] or complete 
genomic sequences [156–160] recognized five distinct DENV-1 genotypes. Our current analysis, based 
on  the  complete  E  gene  sequences  of  1812  DENV-1  strains,  confirms  the  previously  identified Viruses 2011, 3                         
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lineages. Additionally our expanded sequence dataset allows for a detailed phylogeographic analysis of 
DENV-1 (Figure 2).  
Figure 2. Dengue Virus Type 1 Phylogeny. Maximum Likelihood Tree (MLT) of DENV-1 
based on complete E gene nucleotide sequences of all available naturally occurring strains 
(n = 1812) from GenBank. MLT was reconstructed using PAUP* version 4b10-MacOsX 
package  [161],  employed  the  NNI  branch  swapping  method,  and  based  on  the  best-fit 
nucleotide  substitution  model  estimated  by  MODELTEST  [162].  Bootstrap  values  (NJ 
method with 1000 replications) above 70 were labeled along the branch of major clades. 
The tree is mid-point rooted. Color lines represent specific geographic regions as specified 
within the figure. 
 Viruses 2011, 3                         
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The  identified  lineages  are  grouped  in  5  genotypes  as  follows:  (a)  genotype  I,  representing 
strains from  throughout  Southeast  Asia,  China  and  the  Middle  East  (Saudi  Arabia).  Within  this 
genotype there are several distinct clades associated with outbreaks sharing specific spatiotemporal 
associations [151,156,157,163]. Of note are the Malaysia and Singapore outbreaks of 2003 through 
2008 that resulted in several spillovers into China, Taiwan, Japan and South Korea [154,164,165], as 
well  as  a  series  of  Vietnam  and  China  outbreaks  sampled  between  2001–2003,  and  2003–2008 
suggesting Cambodia as the major source of DENV-1 outbreaks [157,166,167] (Figure 2). Of interest 
is  the  2004  outbreak  in  China  where  a  combination  of  human  movement  and  a  natural  disaster 
(typhoon Rananim) led to an explosion of mosquito larval development sites, leading to the outbreak’s 
rapid  spread  throughout  the  region  [168].  The  reality  of  DENV  outbreak  initiations  via  virus 
introduction from other localities is best exemplified by the near simultaneous outbreaks of DENV-1 
in  2001  in  Myanmar  and  several  other  distant  location  throughout  the  Pacific,  which  were 
demonstrated to have been caused by strains from 3 different genotypes [163] (Figure 2). (b) genotype 
II, representing a couple of strains collected in Thailand during the 1950s and 1960s. These strains 
have not been sampled since, suggesting that either they have become extinct or are circulating at such 
a  low  frequency  in  niche  environments  to  have  escaped  surveillance.  (c)  genotype  III  (sylvatic?), 
representing what was thought initially to include the only 2 putative sylvatic isolates collected in 
Malaysia. The sylvatic nature of these isolates has recently been questioned based on discrepancies in 
topology by analyses performed on E gene [63] or complete genome sequences [58,94]. The latter 
analyses do not place the Malaysian canopy DENV-1 isolates in a basal position within this serotype, 
an  observation  confirmed  by  our  current  analysis  of  expanded  E  gene  sequences.  Therefore,  it  is 
possible that these isolates in fact represent spillback events from humans into monkeys rather than 
true sylvatic isolates. This hypothesis is further supported by the 2005 isolation of human DENV-1 
from Malaysia that clusters with the 1972 isolate on the phylogenetic tree [150] (both isolates are 
depicted in Figure 2 as ‘Malaysia72-05’). Although the authors interpreted this as evidence for the 
sustained transmission of sylvatic DENV-1 in Malaysia, the fact that both of these strains fall within 
the  mainstream  diversity  of  human  DENV-1  suggests  that  they  are  ultimately  of  human  origin. 
(d) genotype IV, representing strains from countries of the Pacific Rim (from Japan, Korea, China, 
Myanmar, Malaysia and Indonesia) [163], the Western Pacific islands (for example French Polynesia, 
Nauru,  The  Philippines  and  Hawaii),  and  Australia.  Our  analysis  confirms  previous  reports  that 
the 2001 DENV-1 outbreak in Hawaii was imported from Tahiti and Samoa [169], and that the 2004 
outbreak in China was introduced by a traveler returning from Thailand [168]. Similarly, DENV-1 
strains collected during outbreaks from diverse places such as the Caribbean (1977–1985) [170] and 
the  Indian  Ocean  island  of  La  Reunion  (2003–2006),  are  also  grouped  within  this  genotype, 
underscoring the rapid spread of DENV through frequent human movement and global trade. Lastly, 
(e) genotype V represents most DENV-1 strains collected in the Americas, strains from West Africa 
and Asia. The American strains include those collected from Puerto Rico from 1987–1998 [171,172] 
as well as cases imported into the continental USA at the Mexico/Texas border [173] into the Florida 
Keys [174] (and reviewed in [175]), Central America (Nicaragua, Mexico, Costa-Rica) [155,176,177], 
South America (Venezuela, Colombia, Brasil, Paraguay and Argentina) [142,149,160,178–182] and 
the  Caribbean  [183].  Several  sampled  in  islands  of  the  Indian  Ocean  archipelago  (Comorros,  La Viruses 2011, 3                         
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Reunion  and  the  Seychelles)  during  DENV-1  outbreaks  in  1993  and  2003–2004  and  West  Africa 
during the 1960s during the first documented outbreaks in the region [142,184] are also included. 
Overall, the topologies within each DENV-1 genotype are characterized by the basal location of the 
oldest  strains  followed  by  newer  isolates,  suggesting  a  pattern  of  evolution  radiating  around 
spatially-defined (geographic) clades. 
4.2. DENV-2 
Although early phylogenetic studies based on partial (prM/E) [62,185] or complete E gene [186] 
sequences identified 4 major genotypes, subsequent analysis with an expanded E gene dataset revealed 
the existence of two additional genotypes with restricted geographic (Asia-only) distribution [65,187].  
Our  current  analysis  based  on  a  dataset  of  1827  complete  E  gene  sequences  supports  these 
groupings  of  six  genotypes  (Figure  3):  (a)  Asian  genotype  I,  representing  strains  from  Thailand, 
Malaysia, Cambodia, Myanmar, Vietnam and Australia. This genotype includes the reference strain 
16681, isolated in Thailand in 1964 from a patient with severe dengue disease. Recent studies suggest 
that the introduction of this genotype into Vietnam from Thailand sometime in the 1990s led to a series 
of outbreaks and the displacement of the SE Asian/American genotype as the dominant lineage in the 
region (including Cambodia) [188,189]. This rapid displacement by genotype I was attributed to its 
fitness advantage (ability to reach higher viremia in humans), leading to an increased rate of human-to-
mosquito transmission [189]. (b) Asian genotype II, representing strains from China, Indonesia, The 
Philippines, Taiwan, Sri Lanka, India, Honduras and Mexico. The Philippine isolates occupy in one 
clade,  which  includes  two  subgroups  divided  chronologically  [187].  The  sole  Taiwanese  isolate 
represents an imported strain from the Philippines during the 1998 outbreak [190]. This genotype 
includes the prototype strain New Guinea C (NGC) isolated in 1944 [74]. Several strains isolated 
independently in different parts of the world (for example, Honduras, Mexico, China) are genetically 
similar to the NGC prototype strain [65,191–193] (and reviewed in [194]) (Figure 3). Given the rapid 
DENV nucleotide substitution rates and the limited genetic diversity among these samples, they most 
likely  represent  laboratory  contaminations.  (c)  Southeast  (SE)  Asian/American  genotype.  This 
genotype’s topologies suggest a spatial division into two major subclades: (i) all strains collected from 
Southeast Asia, and (ii) strains collected in Central and South America and the Caribbean over the 
last 30 years (Figure 3). The founder of this clade was most likely introduced from Vietnam into Cuba 
in 1981 [195], with profound public health consequences. This Cuban epidemic was associated for the 
first time in the Western hemisphere with severe disease. Because of the strength of the Cuban public 
health  infrastructure,  although  there  were  several  thousand  cases  of  severe  dengue  disease,  the 
case-fatality rate was low [195]. Nonetheless, during the next 30 years strains of this genotype were 
responsible for major epidemics with increased pathogenicity throughout the Americas. Because of 
their increased fitness, these viruses displaced less virulent strains of the American genotype from 
many regions in the Americas [77,196]. (d) Cosmopolitan genotype, previously designated as genotype 
IV [186], representing strains distributed in a wide geographic area, including East and West Africa, 
the Middle East, the Indian subcontinent, Indian and Pacific Ocean Islands and Australia. Recently 
strains of this genotype have been collected in Mexico [153]. As the topologies suggest, there is a 
spatial subdivision into two subclades (Figure 3): (i) a subclade dominated by strains isolated from the Viruses 2011, 3                         
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Indian subcontinent [197], Bhutan [198], Sri Lanka, Bangladesh [165] and the Seychelles. The Indian 
isolates  are  represented  by  strains  collected  after  1971,  whereas  all  pre-1971  Indian  strains  were 
genetically similar to the American genotype (see below) [197]. Two clusters of DENV-2 isolated in 
Saudi Arabia in 1994 are also included, most likely representing two independent introductions into 
the region by pilgrims from India [199]. A handful of strains from Fiji, Australia, Singapore, Uganda 
and Malaysia are also included. The latter strains are deeply basal, suggesting a Malaysian origin for 
this clade. (ii) a subclade that is truly cosmopolitan, characterized by a global distribution with strains 
sampled as early as 1975 in Indonesia. This subclade is further divided into two distinct groups whose 
common ancestor appears to have originated in Indonesia (Figure 3). Members of one group appear to 
have  radiated  eastward  towards  East  [200]  and  West  Africa  [201],  but  also  westward  towards 
the Torres  Strait  Islands  and  Australia.  Members  of  the  other  group  appear  to  circulate  widely  in 
the countries  of  the  Pacific  Rim,  causing  outbreaks  in  Malaysia  [202],  Singapore  [203],  the 
Philippines [187],  and  Taiwan  [165,204,205].  (e)  American  genotype,  previously  designated  as 
genotype  V  [186],  representing  strains  from  Central  and  South  America,  the  Caribbean  and  older 
strains collected in the Indian subcontinent and the Pacific Islands. The Indian strains form a distinct 
lineage within this genotype and include all isolated prior to 1971. This lineage was later replaced by 
strains  of  the  Cosmopolitan  genotype  [206].  Isolates  of  this  lineage  form  3  distinct  subgroups, 
suggesting  that  these  viruses  were  introduced  at  least  thrice  into  India  from  South  America 
immediately after World War II, a time coinciding with increased movement of ethnic Indians from 
South America to India and back [197]. Historically, strains of this genotype have been associated with 
mild  DEN,  an  observation  corroborated  by  experimental  data  [77,78,81,207,208],  and  thus  are 
considered  to  have  a  low  epidemiological  impact  [192,196,207].  However,  recent  analyses  [209] 
indicate  that  outbreaks  of  this  genotype  in  the  1970s  in  Puerto  Rico  [210],  Tahiti  [211],  New 
Caledonia [212] and Niue [213] included severe dengue disease.  Lastly,  (f) the sylvatic  genotype, 
representing strains from humans [97,214–219], canopy-dwelling arboreal mosquitoes [3,95,96,105,220] 
and non-human primates [2,108] collected in West Africa and Southeast Asia as recently as two years 
ago.  This  genotype  is  the  most  genetically  distinct  and  lies  basal  to  all  other  DENV-2  lineages, 
supporting the hypothesis that it represents the ancestral genotype. Within this genotype, the Asian 
strains are genetically distinct from the West African strains. Recent research has demonstrated that 
sylvatic DENV evolves in a manner similar to that of human DENV, suggesting that the dynamics of 
mutation, replication, and selection are broadly equivalent for DENV-2 across its host range [221]. 
This  rapid  nucleotide  substitution  rate  is  evident  in  the  delineated  chronologic  divide  among  all 
pre-1980 isolates, which form a group distinct from all post-1980 isolates (Figure 3) [97]. In agreement 
with  the  historical  record,  our  analysis  has  confirmed  the  oscillating  nature  of  the  sylvatic 
amplification cycles in West Africa, in which silent intervals (lack of virus isolates from mosquitoes) 
of about 8–10 years in length terminate in abrupt spikes of DENV circulation (as detected in 1966, 
1974,  1980–1982,  1989–1990,  1999–2000).  Human  DENV-2  isolations  coinciding  with  these 
amplification cycles suggests that sylvatic DENV are not confined into the forest but the have the 
potential to cause limited spill-overs, even in urban settings [97]. These cases revealed that clinical 
illness resulting from sylvatic DENV infection can be indistinguishable from classic DF resulting from 
the human transmission cycle. However, two recent cases from Malaysia [215] and Guinea-Bissau 
demonstrate  that  sylvatic  DENV  infection  can  also  cause  severe  disease  [219].  The  latter  case  is Viruses 2011, 3                         
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striking given that severe dengue disease is rare in Africa, even during urban transmission of typical 
human strains. 
Overall,  there  is  considerable  genetic  diversity  within  the  DENV-2  genotypes,  reflecting  their 
continual divergence and diverse geographic distribution.  
Figure 3. Dengue Virus Type 2 Phylogeny. Maximum Likelihood Tree (MLT) of DENV-2 
based on complete E gene nucleotide sequences of all available naturally occurring strains 
(n = 1827) from GenBank. MLT was reconstructed using PAUP* version 4b10-MacOsX 
package  [161],  employed  the  NNI  branch  swapping  method,  and  based  on  the  best-fit 
nucleotide  substitution  model  estimated  by  MODELTEST  [162].  Bootstrap  values  (NJ 
method with 1000 replications) above 70 were labeled along the branch of major clades. 
The tree is mid-point rooted. Color lines represent specific geographic regions as specified 
within figure. 
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4.3. DENV-3 
In  1994  Lanciotti  delineated  for  the  first  time  4  distinct  DENV-3  lineages  corresponding  to  4 
distinct genotypes [222]: (a) genotype I, representing strains from southeast Asia, the Philippines and 
the  South  Pacific  islands;  (b)  genotype  II,  representing  strains  from  continental  Southeast  Asia; 
(c) genotype III, representing strains that spread across Asia, East Africa and into the Americas; and 
(d)  genotype  IV,  representing  strains  from  Puerto  Rico  and  Tahiti.  Several  subsequent  DENV-3 
phylogenies based on the E gene [69,202,223–232], partial gene(s) or gene junctions (e.g., C, prM/E, 
NS3) [83,233–236] or complete genome [237–239] sequences have confirmed these genotypes.  
Our current analysis based on complete E gene sequences of 1208 DENV-3 strains available in 
GenBank  confirms  in  principle  the  previously  identified  genotypes,  but  also  allows  for  greater 
resolution to delineate the presence of a new genotype (genotype V) as recently suggested [239–241]. 
The  identified  lineages  are  grouped  into  5  genotypes  (Figure  4a)  as  follows:  (a)  genotype  I, 
representing strains from the maritime areas of Southeast Asia, mainly Indonesia, Singapore, Malaysia, 
the Philippines and Taiwan [239], and the islands of the South Pacific (e.g., Fiji and Tahiti) [242] 
(Figure 4a).  This  genotype  includes  the  majority  of  isolates  from  Indonesia  from  1973–1983  and  
1998–2009 [152,222,243–246], the East Timor outbreaks of 2000–2005 [247–249], two of the earliest 
samples collected in Malaysia (1974 and 1981) [222,250] and a single isolate from Thailand [143]. 
The single Thai strain within this genotype raises a few questions, namely was its failure to establish 
itself:  (i)  a  reflection  of  regional  differences  in  vector  competence?  (ii)  loss  in  a  competition 
among genotypes?  (the  predominant  circulating  DENV-3  genotype  in  Thailand,  is  genotype  II). 
(iii) neutralization due to immunity to closely related strains within a pre-exposed human population, 
which  would  severely  limit  the  available  pool  of  susceptible  hosts  to  maintain  transmission? 
(iv) sampling bias? (it is quite possible that strains of this genotype have been circulating as minor 
variants  and  thus  remained  undetected).  Overall,  it  appears  that  genotype  I  has  been  evolving 
independently  in  Indonesia  [69]  over  the  past  30  years  and  radiating  westward  reaching  French 
Polynesia, and northward reaching the Philippines and Taiwan, leading to the first recorded cases of 
DENV-3-induced severe disease there [239], Tahiti [251] and recently in Brazil [252]. (b) genotype II, 
representing  nearly  all  strains  sampled  in  Thailand  from  1962  until  recently  in  various  epidemics 
(e.g., 1974–1989,  1980–1991,  1988–1991,  etc.),  a  single  strain  from  Singapore  collected  in  1995 
(GenBank  accession  no.  AY766104),  one  isolate  from  Indonesia  sampled  in  1998  [243],  Taiwan, 
Vietnam, Bangladesh [253,254], Cambodia, China, Japan and Myanmar (Figure 4a). In contrast to a 
recent  report  by  Araujo  et  al.  [69],  where  the  1962  Thailand  isolate  was  shown  to  reside  near  a 
common ancestral node of genotype II and III, our analysis shows that this isolate is basal within 
genotype II. Overall it appears that genotype II has been evolving independently in Thailand over the 
past  50  years,  radiating  in  countries  of  the  continental  Southeast  Asia  with  occasional  forays 
(importations)  into  Taiwan,  China,  Bangladesh  [69,255]  and  Norway  [256].  (c) genotype  III, 
representing strains from Sri Lanka, India, Japan, Taiwan, Singapore, Samoa, East Africa, Central and 
South America, the Caribbean and a couple of imported strains to Europe (Figure 4a). This genotype is 
the  most  geographically  dispersed  of  all  the  DENV-3  genotypes.  It  appears  to  have  emerged 
somewhere in the Indian subcontinent (in proximity to Sri Lanka), before spreading westward into 
Africa sometime in the 1980s [257] and leapfrogging into the Americas a decade later. Although in Viruses 2011, 3                         
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Figure 4a the African strains appear basal to the contemporaneous Sri Lanka isolates, this topology is 
not highly supported, as the bootstrap value is low. The earliest documented sampling of genotype III 
in the Americas was in 1994 in Panama and Nicaragua [258,259], but some phylogenetic analyses 
point to its introduction through Mexico [260] a few years earlier [69]. Whatever the location and time 
of introduction of this genotype in the Americas might be, it is clear that that these viruses rapidly 
spread throughout the region by several independent routes of introduction through Central America 
[236,258,261,262]  to  the  Caribbean  [263–267]  and  to  South  America  [83,223,225,226,268–270] 
(Figure 4a). The introduction of this genotype into the western hemisphere coincided with explosive 
epidemics  and  an  increased  incidence  of  severe  dengue  disease  [235,236,260,271].  Strains  of  this 
genotype have also radiated eastward as far as Samoa [222] and north as far as Japan, representing 
importation  from  Africa  [228].  This  genotype  has  also  been  recently  sampled  in  China,  probably 
imported from the Indian subcontinent [272]. (d) genotype IV, representing strains sampled in Puerto 
Rico in the early 1960s to late 1970s and in Tahiti. This genotype is the most genetically distinct from 
all other genotypes of DENV-3 and has only been associated with classic dengue disease [210,273,274]. 
The position of the sampled strains within this genotype corresponds nicely with the epidemiological 
record. For example, serologic analysis [275] of strains from the 1963 DENV-3 epidemic in Puerto 
Rico [273] and the 1965 Tahiti epidemic [274] indicated strong similarities, suggesting that viruses 
responsible for the Tahiti epidemic were introduced from Puerto Rico (Figure 4a). Furthermore, the 
low pathogenic potential of these strains may be responsible for a silent epidemic in either location. 
For example, it is believed that the virus was continually circulating in Tahiti for 4 years until another 
outbreak of DENV-3 took place in 1969 [276]. Similar to Puerto Rico, the genetic data indicate strains 
of the 1963 and 1967 Tahitian epidemics (Figure 4a) are closely related, suggesting that the virus was 
maintained in a silent transmission. Lastly, (e) genotype V, representing the prototype DENV-3 strain 
(H87–1956)  from  the  Philippines  [277],  includes  an  1973  isolate  from  Japan,  strains  from  China 
(sampled in 1987 and 2009) and strains from Brazil sampled in the early 2000s. The lineages within 
this genotype raise an interesting and intriguing question: why strains sampled in Brazil in 2002–2004 
[240,241] and China in 1980 (GenBank accession no. AF317645) and again in 1989 [278] shared 
very similar sequences with the prototype strain H87 that was isolated nearly 50  years ago in the 
Philippines [277] (Figure 4b)? Taking into consideration the rapid nucleotide substitution rate that is 
characteristic  of  DENV  [67,69,71,221,279–282],  it  is  highly  likely  that  these  samples  represent 
laboratory contaminations. Viruses 2011, 3                         
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Figure  4.  (a)  Dengue  Virus  Type  3  Phylogeny.  Maximum  Likelihood  Tree  (MLT)  of 
DENV-3  based  on  complete  E  gene  nucleotide  sequences  of  all  available  naturally 
occurring strains (n = 1208) from GenBank. MLT was reconstructed using PAUP* version 
4b10-MacOsX package [161], employing the NNI branch swapping method, and based on 
the  best-fit  nucleotide  substitution  model  estimated  by  MODELTEST  [162].  Bootstrap 
values (NJ method with 1000 replications) above 70 were labeled along the branch of 
major  clades.  The  tree  is  mid-point  rooted.  Color  lines  represent  specific  geographic 
regions as specified within figure. (b) Genotype V lineage discrepancies. 
(a) 
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Sylvatic  DENV-3  are  believed  to  circulate  in  Southeast  Asia  based  on  the  seroconversion  of 
sentinel  non-human  primates  [283].  Although  no  virus  isolation  has  been  reported  to  date, 
uncorroborated reports suggest that a sylvatic DENV-3 strain may have been isolated in Vietnam in the 
1970s [284].  
Overall, DENV-3 evolution is characterized by discrete monophyletic and geographically distinct 
clusters,  suggesting  spatially  contained  population  bursts  with  limited  co-circulation  of  various 
genotypes and occasional but robust gene flow among geographic regions. 
4.4. DENV-4 
While the seminal work of Lanciotti et al. [281] and Wang et al. [63] identified only 2 genotypes of 
DENV-4 based on limited E gene sequences, subsequent analyses based on larger datasets delineated  
4 major genotypes [58,70,98,280,285]. Our current analysis, based on 418 E gene sequences sampled 
from 1956 to 2008, confirmed the existence of 4 genotypes and provided greater resolution than the 
previously identified topologies. These genotypes include: (a) genotype I, representing strains from 
The Philippines, Thailand, Vietnam, Myanmar, Malaysia, Sri Lanka, India [286,287], and a handful of 
imported cases in Japan [255], China [256] and Brazil [288,289]. This genotype includes the prototype 
DENV-4 isolate (H241) isolated in the Philippines in 1956 [277]. (b) genotype II, representing strains 
from  throughout  Southeast  Asia  (Indonesia,  Malaysia,  Singapore),  China,  islands  of  the  Western 
Pacific Ocean, Australia, the Caribbean and the Americas (Figure 5). Recently, strains of this genotype 
reached Easter Island [290]. As the topologies suggest, there is a spatiotemporal subdivision into two 
clades: (i) clade I, represents all strains isolated in the Americas and most Asian strains (Indonesia, 
New Caledonia, Singapore, Malaysia and Tahiti) collected prior to 2000 (Figure 5). The introduction 
of this genotype from Southeast Asia in the Americas took place sometime in the early 1980s through 
the Caribbean [291], although Carrington suggested introduction through South America [292]. The 
former  hypothesis  is  further  supported  by  serologic  evidence  relating  these  strains  to  viruses 
circulating in French Polynesia a year before the onset of the Caribbean epidemics [147]. From the 
islands  of  the  Lesser  Antilles  this  lineage  spread  throughout  the  Caribbean  [293–295]  and  on  to 
South [296] and Central [153,281] America (and reviewed in [70]); and (ii) clade II, represented by all Viruses 2011, 3                         
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but  three  Asian  strains  collected  after  2000  (Figure  5).  Within  this  clade  is  a  distinct  lineage  of 
Malaysian strains that AbuBakar suggested may have emerged through intra-serotypic recombination 
of  two  ancestral  strains  [285].  (c)  genotype  III,  represented  by  five  recent  Thai  strains  isolated 
between 1997 and 2001, appears to be distinct from all other Thai isolates [280]. Lastly, (d) genotype 
IV, representing the only three known sylvatic DENV-4 strains isolated from sentinel monkeys in 
Malaysia  during  the  1970’s.  All  sylvatic  DENV-4  strains  are  genetically  distinct  and  basal  to  the 
clades I-III that represent strains from the human transmission cycle, supporting the notion that they 
represent the ancestral genotype [63,64,94].  
Figure 5. Dengue Virus Type 4 Phylogeny. Maximum Likelihood Tree (MLT) of DENV-4 
based on complete E gene nucleotide sequences of all available naturally occurring strains 
(n = 418) from GenBank. MLT was reconstructed using PAUP* version 4b10-MacOsX 
package  [161],  employed  the  NNI  branch  swapping  method,  and  based  on  the  best-fit 
nucleotide  substitution  model  estimated  by  MODELTEST  [162].  Bootstrap  values  (NJ 
method with 1000 replications) above 70 were labeled along the branch of major clades. 
The tree is mid-point rooted. Color lines represent specific geographic regions as specified 
within figure. 
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Overall, the strain topologies within each genotype are characterized by the basal location of the 
oldest strains followed by newer isolates, suggesting a pattern of evolution radiating around temporal 
rather than spatial (geographic) clades [291,297]. Remarkably, among the two major genotypes (I and 
II) there appears to be limited genetic exchange; genotype I circulates exclusively in Southeast Asia 
while genotype II has been evolving independently in Southeast Asia and the Americas for the past 
three decades. This pattern of isolation has been recently confirmed by other investigators [70]. 
5. Basis of Genetic Diversity of DENV 
As stated above, phylogenetic and molecular epidemiology data indicate that DENV consist of four 
distinct serotypes, namely DENV-1, -2, -3, and -4, which differ at levels similar to those between 
different  flavivirus  species  [298].  Furthermore,  each  of  the  serotypes  contains  a  number  of 
genotypes [62,65,69,70], usually associated with different geographical distributions, and which also 
contain  more  detailed  genetic  infrastructure  reflecting  the  local  dispersal  of  viral  strains  (shown  in 
Figures 2–5). 
The  fundamental  basis  of  DENV  genetic  diversity  can  be  attributed  to  its  error-prone 
RNA-dependent  RNA  polymerase,  which  does  not  have  proof-reading  capacity  and  is  thought  to 
produce approximately one mutation per round of genome replication [299,300]. Analyses based on 
selective pressures, represented as the ratio of nonsynonymous to synonymous substitutions (dN/dS), 
per site suggest that the majority of DENV mutations are deleterious and subject to strong purifying 
selection  (dN/dS  <<  1)  [301].  However,  genetic  variation  and  population  diversity  probably  allow 
DENVs  to  occupy  new  ecological  niches  or  to  adapt  to  changing  niches  and  selective  pressures. 
Correspondingly,  dengue  viruses  evolve  in  a  rate  around  or  just  below  1  ×  10
−3  subs/site/year 
[67,70,71,197,221,227,302,303], to some extent lower than many acutely infecting RNA viruses that 
are directly transmitted between vertebrate hosts [279], indicating that DENV may be subjected to 
stronger evolutionary constraints than the latter.  
Another major way of introducing genetic diversity into viral populations is through migration. As 
discussed above, DENVs have been hyperendemic in Southeast Asia since the 1950s, facilitated by the 
spread of their mosquito vector, the massive movement of troops and human populations during World 
War II, as well as uncontrolled urbanization, lack of basic infrastructure and deforestation [7,304]. In 
the  Americas,  the  cancellation  of  the  vector  eradication  programs  in  the  1970s  facilitated  dengue 
re-emergence  in  various  regions  of  Central  and  South  America  through  the  re-introduction  and 
re-colonization of the primary domestic vector Ae. aegypti aegypti. As a consequence, between the 
1980s and 1990s many Latin American countries evolved from non-endemic (no virus present) or 
hypo-endemic (one serotype circulation) to hyperendemic [305]. Indeed, growing evidence indicates 
that  DENV  gene  flow  is  a  common  phenomenon  and  occurs  on  various  scales  [188,291,292]. 
Serotypes and genotypes can be introduced into broad geographical areas where genetically distant 
strains are already endemic, dramatically increase the genetic diversity and leading to larger fitness 
variations. In addition to innate viral factors, cross-immunity and antibody-dependent enhancement 
(ADE) put the fitness of invading strain on a more complicated landscape. 
Furthermore,  it  is  noteworthy  that  the  increased  host/vector  population  sizes  and  densities 
themselves may help to maintain DENV  genetic diversity by increasing the transmission rate and Viruses 2011, 3                         
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therefore the total viral population size and amount of replication. A large population size not only 
directly provides the space for larger population diversity, but also reduces the diversity loss due to 
stochastic events [306].  
Finally, although clonal evolution (i.e., the accumulation of mutational changes) has been presumed 
as  the  major  foundation  of  DENV  evolution,  homologous  recombination  has  been  suggested  as  a 
potentially important factor in increasing genetic diversity in viral population. Indeed, the frequent 
co-circulation of different serotypes and/or genotypes in one region (see below), together with the fact 
that Ae. aegypti aegypti often engorges multiple times on different hosts [307], makes co-infection of 
genetically distant DENV strains possible in both mosquito and human hosts. Consequently, concurrent 
human  infection  by  two  or  more  DENV  serotypes  appears  to  be  a  common  occurrence  [305]  and 
putative  recombinants  have  been  detected  within  a  single  mosquito  [308].  Several  reports  have 
suggested that intra-serotype recombination occurs in all DENV serotypes in different geographical 
regions  [309–316].  Furthermore,  the  putative  evidence  of  intra-serotypic  recombination  amongst 
DENV-4 from independent ancestral lineages (most likely Indonesia 1976 and Malaysia 1969) may 
have contributed to the emergence of a distinct genotype, representing all Malaysian strains [285]. In 
contrast,  no  recombination  between  serotypes  has  been  detected,  suggesting  that  molecular 
mechanisms may prevent such event.  
However, despite of many reports of putative recombinant DENV strains, no solid evidence has 
been obtained to attribute the emergence of strains to recombination. In other words, if recombination 
does occur, it usually confers no significant selective advantage. With the dramatic increase of the 
amount of sequence data deposited in GenBank through the collaborative effort of the Broad Institute 
with a variety of international research centers, detection of the frequency of recombination may be 
evaluated more accurately. However, extreme caution should be exercised when detecting putative 
recombination  events.  To  date  all  reported  recombination  events  among  flaviviruses  have  been 
detected through phylogenetic methods, such as bootscanning. For natural recombination to lead to 
transmission, three conditions must be met: (a) the recombinant crossover should be demonstrated in a 
single PCR amplicon following cloning to ensure that it occurs in a single cDNA molecule; (b) the 
recombination should be demonstrated repeatedly in clonal populations of viable virus (for example, in 
plaque  harvests  or  limited  endpoint  dilution  isolates);  and  (c)  the  recombinant  should  be  stably 
maintained during post-recombination evolution [98,310]. 
6. Evolution Pattern and its Driving Forces 
6.1. Dengue Evolution is Characterized by Frequent Lineage Replacement 
The evolution of DENV has been associated with its global expansion in the last half of the 20th 
Century, due to the global spread of the anthropophilic vector Ae. aegypti aegypti, the increase of the 
human  population  size,  uncontrolled  urbanization,  and  expansion  of  international  commerce  and 
travel [317,318]. At local levels, phylogenetic analyses based on longitudinal data have suggested a 
continuous  clade  turnover  process  (although  not  as  striking  as  in  Influenza  viruses)  whereby 
individual lineages or entire clades of viruses frequently arise, persist for a period of time, and then 
disappear [144,319]. Replacement can occur along a single lineage, as is reflected by the ladder-like Viruses 2011, 3                         
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topology on the phylogenetic tree, due to the regular bottlenecks in viral population size associated 
with the seasonal fluctuation of vector population size and density [320], purifying selection, which 
removes all viral strains containing deleterious or slightly deleterious mutations [280,301], or selective 
sweeps. Often, a clade can disappear after circulating in a particular area for several years and be 
replaced by a new clade sometimes associated with an epidemic outbreak [163,187]. Related to this 
clade replacement, co-circulation of different viral strains (including serotype, genotype, or group of 
viruses  within  a  genotype)  is  often  observed,  although  with  various  spatiotemporal  associations 
(see Sections 6.2–6.4 below). Unclear are the detailed mechanisms which lead to clade replacement 
and which determine the fate of the introduced strains. 
6.2. The Role of Selection Pressures on Shaping the Evolution and Population Dynamics of DENV 
One of the central questions in DENV evolution is how much effect natural selection imposes on its 
evolutionary dynamics? Theoretically, viral strains with higher virulence (if accompanied with higher 
and  longer  in  duration  viremia  leading  to  greater  chance  of  a  mosquito  getting  infected)  and 
transmission rates from the host, higher infection and dissemination rates in the mosquito vectors, or 
different antigenicity from previous circulating strains, will be favored by natural selection. Despite the 
evidence that DENVs are generally under strong purifying selection [301], a few putatively positively 
selected codons have been detected phylogenetically in several genes (E, NS2A, NS2B, NS4B, and 
NS5) [65,66,156,197,221,297]. Positively selected codons in the E gene are located either in T- or 
B-cell  epitopes,  indicating  they  are  likely  involved  in  escaping  the  host  adaptive  immunity,  or  in 
regions  that  affect  membrane  fusion  [64–66].  However,  selective  pressures  acting  on  different 
serotypes or genotypes can differ. For example, the Cosmopolitan genotype of DENV-2 exhibits an 
elevated dN/dS value compared to other genotypes, suggesting adaptation during its global spread. Of 
specific interest is codon E-390, previously identified as a key virulence determinant [321] that could 
play a role in viral pathogenicity and/or transmissibility due to its location within the distal face of 
domain III, a region associated with attachment to host cells. Furthermore, the estimation of positively 
selected codons often varies because it is a function of the spatial and temporal composition of the 
sample sets [197], suggesting that selection pressure varies in different ecological environments, and 
often acts on a local scale. For example, a study of DENV-4 evolution over 20 years in Puerto Rico 
indicated that positive selection (supported by high dN/dS values and rapid fixation rates) on NS2A, can 
at least partially be contributed to lineage turnover [297]. Similarly, positively selected sites on the E 
gene, which encodes proteins on the viral surface that enable host-cell binding and entry and also 
provide the primary target for host immune responses, may explain, at least in part, the fixation of the 
SE Asian/American genotype of DENV-2 in Puerto Rico [322].  
Additional experimental lines of evidence have illustrated that fitness variation does exist between 
different genotypes and even among strains belonging to a single genotype. For example, the Southeast 
Asian genotype of DENV-2, which was introduced to the Americas in the late 1970s, has effectively 
replaced the American genotype due to its higher infectivity for Ae. aegypti aegypti [77,81,82] and 
higher viral output in the humans [77,78,207,323]. Similar observations were observed in the Asian 1 
lineage of DENV-2, which have entirely displaced the previously dominant Asian lineage in Vietnam, Viruses 2011, 3                         
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Thailand and Cambodia. A selective sweep is supported by the significantly higher plasma viraemia 
levels in pediatric patients, which probably leads to more efficient human-to-mosquito transmission [189]. 
However, although small differences in viral fitness can explain the rapid expansion and fitness of a 
novel genotype, modeling work suggests that the fate of an introduced strain, even with slight fitness 
advantage, is ultimately determined by the epidemiological landscape (a combination of factors such 
as  density  of  mosquito  vector  population,  fluctuation  of  biting  frequency,  and  a  period  of 
cross-immunity, etc.) in which it arose [324]. 
6.3. Cross-Immunity as a Driving Force for DENV Evolution 
Several  phylogenetic  studies  have  explored  the  traces  of  positive  selection  imposed  by  the 
cross-immunity by different serotypes on the evolution of DENVs. It has been suggested that rapid 
transmission of DENV populations occurring during concurrent serotype outbreaks may give rise to 
serologic-escape mutants due to the presence of cross-immunologic pressures [325]. For  example, 
during  the  2001  outbreak  of  DENV-1  in  Myanmar,  which  followed  the  1998  outbreak  caused  by 
the co-circulation  of  all  four  DENV  serotypes,  six  of  the  eight  amino  acid  substitutions  that 
distinguished  [151]  the  post-1998  DENV-1  strains,  as  well  as  all  other  strains  of  co-circulating 
DENV-2, -3, and -4 lineages, were localized in the E protein. This suggested that the presence of 
strong selective pressures imposed on the circulating  DENV-1 strains by  cross-reactive antibodies 
produced against the co-circulating DENV-2, -3, or -4 facilitated their immunologic escape from the 
strong herd immunity shortly after the 1998 outbreak [151]. The interaction of co-circulating serotypes 
may also facilitate the intra-serotypic clade replacement. A longitudinal study over a 30-year span in 
Thailand revealed an inverse correlation between prevalence of DENV-1 and DENV-4 [144]. Increase 
of prevalence of DENV-1 was often accompanied by an increase in its clade diversity, whereas clade 
replacements  by  genotype  often  occurred  with  a  decline  of  that  serotype,  possibly  due  to  their 
differential  susceptibility  to  cross-reactive  immune  response  ilicited  by  other  serotypes.  This 
observation  is  further  supported  by  epidemiological  models  in  Thailand  [326],  suggesting  that 
moderate  cross-protective  immunity  gives  rise  to  persistent  out-of-phase  oscillations,  as  shown  by 
DENV-4  circulation  during  interepidemic  years.  However,  strong  or  weak  cross-protection  or 
cross-enhancement  only  produces  in-phase  patterns,  as  shown  by  the  long-term  co-circulation  of 
DENV-1, -2, and -3 [326]. 
6.4. Stochastic Events Play an Important Role in Clade Replacement 
The indications of purifying selection (dN/dS << 1) in phylogenetic studies along with sporadic 
occurrences of positive selection as the major selective pressure acting upon DENV genomes [65,301], 
the  co-circulation  of  different  genotypes,  rather  than  immediate  replacement  after  introduction, 
highlight the importance of environmental and immunological factors than viral factors in determining 
the occurrence of clade replacement. Possible population bottlenecks between epidemics, as observed 
during the inter-epidemic periods of 1980 and 1987 in Bangkok, was also proposed as a possible 
mechanism based on the observation of the low level of fixed amino acid and nucleotide changes in E 
gene between samples surveyed from the two adjacent epidemics [327]. Similarly, the replacement 
of the  pre-1992  lineage  of  DENV-3  in  Thailand  by  a  local,  rather  than  an  introduced  strain Viruses 2011, 3                         
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during the inter-epidemic  period  was  attributed  to  stochastic  events  occurring  during  population 
bottlenecks [143]. More recently, a comprehensive study examining DENV-1 clade replacement in 
Myanmar [156], where a long-circulated lineage (genotype III) went extinct following the introduction 
of two new clades (genotype I) in 1996–1998, suggested that positive selection was not responsible for 
the extinction of genotype III virus. Rather, it was due to a stochastic event attributable to the low rate 
of virus transmission during an inter-epidemic period [156]. 
6.5. Antibody-Dependent Enhancement (ADE) and Its Effect on DENV Evolution 
Antibody-dependent enhancement (ADE) is a proposed biological mechanism that influences the 
uptake  of  DENV  by  target  cells  of  infection,  whereby  DENV  replication  is  increased  rather  than 
decreased by humoral immunity derived from a previous DENV infection, and has been suggested as 
one  of  the  mechanisms  responsible  for  severe  dengue  disease  [328,329].  The  generation  of 
non-cross-neutralizing antibodies raised against a primary DENV infection leads to the formation of 
infectious  virus-antibody  complexes  upon  a  heterotypic  DENV  infection,  which  bind  to  the  Fc 
receptors  on  the  surface  of  mononuclear  phagocytes  and  facilitate  the  uptake  and  replication  of 
viruses [330]. In vitro and in vivo studies have shown that non-neutralizing antibodies from a previous, 
heterotypic DENV infection enhance the replication of DENV [331] (enhancement of infection) in 
rhesus monkeys [329] and humans [26]. In theory, ADE may lead to an increased cell susceptibility 
(enhanced uptake by macrophages), transmissibility (increased viremia), and mortality (severe dengue 
disease). The roles of these factors in shaping the evolution and population dynamics of DENV have 
been  discussed  in  many  mathematical  modeling  studies.  Using  a  dynamic  system  model  of 
co-circulating  dengue  serotypes,  Cummings  et  al.  [332]  suggested  that  ADE  could  provide  a 
competitive advantage to those serotypes that undergo enhancement compared to those that do not, and 
that this advantage increases with increasing numbers of co-circulating serotypes. However, the role of 
ADE may be limited due to the observation that greater levels of enhancement induce large amplitude 
oscillations in incidence of all dengue virus infections, threatening the persistence of both the enhanced 
and non-enhanced serotypes [332].  
ADE  is  also  thought  to  be  responsible  for  the  large  immunological  distance  between  dengue 
serotypes [64,65,68,333]. Assuming that cross-enhancement acts by increasing the transmission rate of 
secondary infections, Ferguson et al. [76] show that ADE can result in periodic or chaotic coexistence 
of two pathogen strains. But this model fails to make the connection between ADE and immunological 
distance, as immunity and enhancement were represented by the same parameter. In an alternative 
model, Kawaguchi et al. [334] assume that increased mortality is the main effect of ADE, and the 
interplay between ADE and cross-immunity can explain the co-circulating pattern of genetically and 
immunologically  distinct  serotypes.  However,  this  model  is  thought  to  have  used  unrealistic 
parameters,  which  do  not  fit  the  epidemiology  and  immunology  of  DENV.  To  overcome  these 
shortcomings and to clarify the effects of ADE, Adams and Boots [335] incorporated parameters of 
enhancement in susceptibility, transmissibility and mortality separately and confirmed their results for 
reasonable levels of susceptibility and transmission enhancement but not for mortality enhancement. 
The authors also showed that when the two strains have identical basic reproductive rates, no form of 
enhancement can lead to competitive exclusion. When strains differ in basic reproductive numbers, Viruses 2011, 3                         
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susceptibility or transmission enhancement allows strains with  greater  immunological similarity  to 
stably coexist but mortality enhancement forces the strains to be more distinct.  
7. DENV Evolutionary Rates and Their Constraints 
To date, several studies that have examined DENV evolutionary rates, mostly by measuring their 
substitution rates based on the E gene, have suggested broadly similar rates from 4.6–11.6 × 10
−4 
subs/site/year, for different serotypes, genotypes and transmission cycles [63,67,72,197,221,227,302,303]. 
These rates are similar to those of many other vector-borne viruses, but in general lower than other 
acutely infecting RNA viruses that are transmitted directly among vertebrates (usually on the order of 
×10
−3 such as Influenza viruses [279]). These relatively low evolutionary rates, together with the low 
dN/dS values observed on DENV evolution, suggests that DENV may be subjected to certain additional 
functional or ecological constraints.  
The most common idea is that vector-borne viruses are subjected to fitness trade-offs due to their 
alternating infections between invertebrate  and  vertebrate hosts.  In theory, adaptations to different 
habitats  or  hosts  are  antagonistic;  alleles  beneficial  in  one  host  impair  fitness  in  others.  Hence, 
different selection pressures between vector and primate host may impose additional constraints on 
vector-borne viruses compared to those transmitted only among vertebrates. Freeing arboviruses from 
alternating host infections by serial passage in vitro [336–342] or in vivo [343] consistently leads to 
an increased fitness in the adaptive cell line or host/vector. Shared mutations in the same position 
from independent  passage  series  suggested  convergent  evolution  via  positive  selection  during 
adaptation [98,344]. Confounding results, however, are observed in the fitness change in the bypassed 
cell  line  or  hosts,  as  well  as  in  alternate  passages.  First,  despite  the  fact  that  most  of the  studies 
suggested a fitness loss in the bypassed cell line after serial passage in a single cell line, some studies 
on vescicular stomatitis virus (VSV) [345] and eastern equine encephalitis virus (EEEV) [346] did not 
find evidence of fitness trade-offs for the bypassed host. Second, with the exception of Venezuelan 
equine  encephalitis  virus  (VEEV)  [343],  all  other  experimental  studies  did  not  observe  fitness 
constraints imposed by alternating passages. In contrast, most of the studies (as mentioned above) 
suggested that alternating passages increase the viral fitness on both cell lines, in a level similar to the 
fitness change after serial passages in the specific cell line. The phenotypic change, however, may not 
be  paralleled  by  genomic  changes.  It  was  observed  that  single  host  cell  passage  resulted  in  the 
accumulation  of  more  mutations  than  alternating  cell  passages  without  causing  obvious  fitness 
deviation  [337],  suggesting  that  constraints  in  evolutionary  rates  do  not  necessarily  correspond  to 
constraints in fitness. Furthermore, despite the fitness increase, few mutations (if any) were observed 
based on consensus sequences, suggesting that fitness increases were mediated by minority genomes in 
the mutant spectrum [343]. To further examine this idea, Coffey et al. [342] measured the genetic 
diversity after serial or alternating passage and its relationship with fitness change and adaptability to 
novel selective pressures. The results suggested that alternately passaged Chikungunya virus (CHIKV) 
is associated with greatest fitness increases without drastic changes in genetic diversity, whereas serial 
passage  led  to  greater  increase  in  genetic  diversity,  indicating  an  evolutionary  trade-off  between 
maintaining  fitness  for  invertebrate  and  vertebrate  cell  cycling.  Lastly,  these  results  also  provided 
evidence for a positive correlation between genetic diversity and adaptability to new environment, Viruses 2011, 3                         
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indicating  the  role  of  mutations  in  minority  genomes  in  the  exploration  of  genetic  space  and 
corresponding fitness space in novel selective pressure. 
Alternatively, but not mutually exclusively, the observed genetic stability of arboviruses could be 
attributed to the persistent infection in vectors, where the RNA interference mechanism suppresses 
viral replication [347]. Experimental studies have provided evidence that mosquito cells place more 
constraints on the evolution of arboviruses than vertebrate cells. In a study by Chen et al. [348], no 
mutation was observed on the E/NS1 portion of DENV-2 genome after serial passage (20 or 30 times) 
on C6/36 cells, compared to 4 nucleotide substitutions corresponding to 3 amino acid changes after 30 
passages on Vero cells and 1 amino acid change following alternating passages between Vero and 
C6/36 cells. In a more comprehensive study, Vasilakis et al. [336], utilizing both cloned and uncloned 
DENV,  examined  whether  alternating  human-to-mosquito  transmission  may  constrain  DENV 
evolution  by  imposing  constraints  on  replication  in  either  host,  if  fitness  trade-offs  occur.  The 
experimental  observations  suggested  that  DENV  that  were  specialized  in  single  host  cells  (either 
Huh-7, a human hepatocarcinoma cell line or C6/36, a mosquito cell line), exhibited fitness gains. 
However, fitness losses were observed in the bypassed cells, and surprisingly viruses passaged in 
alternating  cycles  between  Huh-7  and  C6/36  cells  exhibited  detectable  fitness  gains  in  both  cell 
lines [336]. Moreover, several amino acid changes were observed that were common in both vertebrate 
and  invertebrate  cell  line  passage  series  suggesting  convergent  evolution  via  positive  selection. 
Although  these  observations  support  the  hypothesis  that  release  of  arbovirus  from  its  alternating 
vector-host transmission cycle will lead to the acquisition of fitness gains for retained vertebrate or 
invertebrate host, there was limited support to the notion that arboviruses, including DENV, will adopt 
a fitness compromise. Moreover, a key observation of this study was that DENV specialization in the 
vertebrate  or  alternating  host  cells  facilitated  the  emergence  of  a  qualitatively  and  quantitatively 
different mutation spectrum than exclusive passage in the invertebrate host cell line, supporting the 
notion that positive selection occurs within the vertebrate host [341,342,348].  
Lastly, deriving inferences on the impact of host alternation on arbovirus evolution must take under 
consideration their inherent properties. Specifically, because of the infidelity of their RNA-dependent 
RNA polymerases (RdRp), arboviruses exist as a swarm of intrahost genetic variants (loosely referred 
to as ‘quasispecies’). An inherent limitation of most of the studies described so far is the utilization of 
consensus sequences to monitor the evolution of viral populations, which in reality only reflect the 
majority  nucleotide  at  any  given  position  of  the  viral  genome  and  not  the  spectrum  of  mutations 
present. Thus, minority mutant populations that may be characteristic of the RNA virus ensemble can 
be  masked  [349].  Utilizing  consensus  sequences  obtained  by  the  amplification  and  sequencing  of 
RT-PCR amplicons excludes other present mutations (albeit at lower frequencies) from detection that 
may also play a role in arbovirus evolution. Further support has been demonstrated in recent studies 
suggesting  that  the  diversity  of  the  intrahost  genetic  variants  can  differ  in  vertebrate  hosts  and 
invertebrate vectors [340,350,351], and that these differences can affect viral virulence [352]. Thus, 
future studies examining the evolution of intrahost genetic variant diversity should capitalize on the 
continued advances in the efficiency, speed and cost of next generation DNA sequencing that can 
efficiently sequence simultaneously a large number of RNA viral genomes. Viruses 2011, 3                         
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8. Conclusions  
The  human  DEN  serotypes  evolved  independently  from  progenitor  sylvatic  DENV  of  each 
serotype, in a series of parallel divergence events occurring after the establishment of sufficiently large 
urban  populations  in  the  Asia-Oceania  region  capable  to  support  a  human  transmission  cycle. 
Consequently, DEN is not new to humanity; it has simply been ushered into our consiousness by the 
escalation of the global DEN pandemic during the past 60 or so years. This escalation is attributed to 
human  behavior  (uncontrolled  urbanization,  population  movement,  unsustainable  vector  control), 
ecologic (global invasion of the major mosquito vectors) and viral (interaction and evolution of the 
four  serotypes)  factors,  that  have  ultimately  led  to  increased  viral  genetic  diversity  and  disease 
severity. Understanding the forces that shape DENV evolution and the extent these forces play in the 
observed  shifts  to  higher  virulence  in  human  infections  is  important  in  developing  effective 
countermeasures, especially in the absence of a licensed vaccine or antiviral therapies to control the 
spread of a DENV pandemic.  
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